Disease
Chronic Obstructive Pulmonary Disease
A progressive, largely smoking-related obstructive lung disease encompassing chronic bronchitis and emphysema, managed with bronchodilators, inhaled corticosteroids, and, in advanced disease, biologics and oxygen therapy.
Total attributable cost
$48.0B
$4,322/patient
Drug spend
$20.9B
$1,887/patient
44% of total cost is drugs
All severities, diagnosed (2022 estimate) · US